Background Concurrent chemoradiotherapy (CRT) is the standard treatment for locally
advanced cervical cancer. We investigated how additional bone marrow sparing (BMS) …

The incidence and mortality of squamous cell carcinoma of the anus (SCCA) is on the rise,
which highlights the unmet need for advances in treatment options. The landscape of …

Simple Summary Squamous-cell carcinoma of the anus, being a rare cancer, requires
national and international collaborations, networking, organizational proficiency and …

Background Treatment-related white blood cell (WBC) toxicity has been associated with an
inferior prognosis in different malignancies, including anal cancer. The aim of the present …

This study assessed the efficacy of chemoradiotherapy for squamous cell carcinoma of the
anal canal (SCCAC). Patients with T1–4N0-3M0 SCCAC received chemoradiotherapy with …

Objective: Active bone marrow (ABM) can serve as both an organ at risk and a target in
external beam radiotherapy. 18F-fluorothymidine (FLT) PET is the current gold standard for …

Introduction Radiochemotherapy (RCHT) for the treatment of anal squamous cell carcinoma
(ASCC) has evolved dramatically, also thanks to intensity-modulated RT (IMRT) and 3D …

Background and objectives: The diagnosis and therapy of squamous cell carcinoma of the
anus may vary significantly in daily clinical practice, even if international guidelines are …

Anal squamous cell carcinoma (ASCC) is a rare disease with an increasing incidence. HPV
infection is associated with up to 93% of cases (1–4). Immuno-evasion plays a significant …

Abstract Background: The use of 2-[18F] Fluoro-2-deoxy-d-glucose ([18F] FDG) in positron
emission tomography/computed tomography (PET/CT) imaging is not specific to oncologic …